Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android. Learn more here!


Advances in stem cell research offer unprecedented opportunities to develop new treatments, disease models, and drug screens for previously untreatable conditions*. These discoveries have captivated the imagination of the lay press and have inspired hope in patients, clinicians, and scientists. Inevitably, in an emerging new field, there are false starts that accompany promising discoveries. If rigorous researchers in the field have difficulty discerning hype from hope, what is a busy clinician to do when confronted with basic questions, such as: “Is stem cell therapy available for my lung disease?” or “Shall I bank my baby’s cord blood in case he/she develops cystic fibrosis or emphysema?” This chapter is designed to describe the quickening pace of stem cell and regenerative medicine research related to lung disease and to place the latest discoveries in a historic context, before discussing future prospects.

Stem cells have been found in an increasing number of tissues whose biology is characterized by rapid turnover of differentiated cells. In these tissues, for example, blood, skin, and intestine, a stem cell hierarchy has been described where rare stem cells proliferate occasionally, giving rise to stem cell daughters or to progenitors that can proliferate rapidly and differentiate into mature cells required for the function of that tissue. These properties of self-renewal and differentiation are the classic hallmarks of stem cells, and their importance in homeostatic maintenance of the blood, skin, and intestine are well accepted.1–3 These features also make stem cells attractive vehicles for clinical applications such as the reconstitution of injured or diseased tissues. Several decades of research, including the seminal bone marrow transplantation work of Till and McCullough,4 has rigorously proved that the hematopoietic stem cell, a cell that constitutes 1 in 10,000 bone marrow cells, can be delivered to a recipient by simple intravenous infusion, reconstituting all cells of the bone marrow and circulating blood for the lifetime of the recipient.1

Given the virtually unlimited self-renewing capacity and blood differentiation repertoire of hematopoietic stem cells, most pulmonologists are surprised to learn that cells of similar capacity have not been reproducibly proven to exist in the lung and may not be necessary for the homeostasis of an organ with a quiescent epithelium that contrasts with the rapidly self-renewing epithelia of intestine and skin.

*The authors have no financial conflicts of interest to disclose.


Because the unperturbed adult lung epithelium displays remarkably slow cell turnover, the post-injury or disease responses of human or animal lung have been studied to elucidate both the proliferation potential and differentiation repertoire of various lung cell types. These injury models have been used to search for potential specialized lung cells that might exhibit stem cell properties, such as self-renewal and multipotent differentiation (reviewed by Rawlins and Hogan).5 In the lung many types of functionally ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.